Sharon Bio-Medicine considers extending maturity of convertible bonds

By Devika Patel

Knoxville, Tenn., Jan. 22 - Sharon Bio-Medicine Ltd. informed the Bombay Stock Exchange that its board of directors will hold an extraordinary general meeting on Feb. 16 to consider extending the maturity date of the company's foreign-currency convertible bonds.

Sharon Bio-Medicine is a Mumbai, India-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.